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AbstractÑ Structural Functional Synergistic Resolution 
Recovery (SFS-RR) is a technique that uses supplementary 
structural information from MR or CT to improve the 
spatial resolution of PET or SPECT images. This wavelet-
based method may have a potential impact on the clinical 
decision-making on brain focal disorders such as 
refractory epilepsy, since it can produce images with better 
quantitative accuracy and enhanced detectability. In this 
work, a method for the iterative application of SFS-RR 
(iSFS-RR) was firstly developed and optimized in terms of 
convergence and input image sizes, and then used for the 
diagnosis of 18 patients with refractory epilepsy. To this 
end, PET/MR images were clinically evaluated through 
visual inspection, atlas-based asymmetry indices (AIs) and 
SPM analysis, using uncorrected images and images 
corrected with SFS-RR and iSFS-RR. Our results showed 
that the sensitivity can be increased from 78% for 
uncorrected images, to 84% for SFS-RR and 94% for the 
proposed iSFS-RR.  Thus, the proposed methodology has 
demonstrated the potential to improve the management of 
refractory epilepsy patients in the clinical routine.  
 
Index TermsÑ PET-MR, Epilepsy, Partial Volume 
Correction, Image processing. 
 
This work was supported in part by public Fondo de Investigaciones 
Sanitarias (DTS14/00158), MINECO (2014/CSUN1/000004) and the EU 
COST Action TD1007 (www.pet-mri.eu). P. Aguiar is awarded a public 
fellowship from Xunta de Galicia (POS-A/2013/00). J. Pardo-Montero 
acknowledges the support of Instituto de Salud Carlos III (Miguel Servet grant 
CP12/03162). 
Jess Silva-Rodrguez, Juan Pardo-Montero and Pablo Aguiar (* 
corresponding author) are with the Molecular Imaging Group in Instituto de 
Investigacin Sanitarias de Santiago de (IDIS), University of Santiago de 
Compostela. Travesa da Choupana s/n, 15706  Santiago de Compostela, 
Galicia, Spain (e-mail: pablo.aguiar@usc.es) (e-mail: jesus.silva@usc.es) (e-
mail: juan.pardo.monteroa@sergas.es). Julia Corts and Jess Lpez-Urdaneta 
are with the Nuclear Medicine Department, Hospital Clnico, Complexo 
Hospitalario Universitario de Santiago de Compostela. Travesa da Choupana 
s/n, 15706  Santiago de Compostela, Galicia, Spain. (e-mail: 
julia.cortes.hernandez@sergas.es) (e-mail: jesus.lopez.urdaneta@sergas.es). 
Xiana Rodrguez-Osorio is with the Neurology Department, Hospital Clnico, 
Complexo Hospitalario Universitario de Santiago de Compostela. Travesa da 
Choupana s/n, 15706  Santiago de Compostela, Galicia, Spain. (e-mail: 
xiana.rodriguez.osorio@sergas.es). Dr Charalampos Tsoumpas is with the 
Division of Biomedical Imaging of the University of Leeds, Worsley 
Building, LS2 9JT, Leeds, United Kingdom. (e-mail: 
c.tsoumpas@leeds.ac.uk). 
I.! INTRODUCTION 
POSITRON Emission Tomography (PET) is a non-invasive 
imaging technique that visualizes the distribution of different 
radiotracers in the body providing functional and molecular 
information on tissues. PET is widely used in neurology for in 
vivo examination of brain functionality allowing the 
quantification of cerebral blood flow, metabolism, receptor 
binding and many other physiological parameters [1]. It is a 
valuable tool for the evaluation of ParkinsonÕs disease, 
HuntingtonÕs disease, multiple sclerosis, dementias and 
epilepsy [2]. In the latter case, PET and subtraction ictal single 
photon emission computed tomography (SPECT) co-
registered to magnetic resonance imaging (MRI), known also 
as SISCOM, are routinely used as complements for MRI in the 
localization of the epileptogenic focus before surgery [3] [4]. 
For this particular application, PET has gained a leading role 
since it has demonstrated to be simpler than SISCOM and 
more sensitive than MRI in certain situations [5] [6]. 
Furthermore, the usability and sensitivity of PET have been 
increased in the later years by two main facts. First, the 
availability of co-registered PET/MR images has improved the 
interpretation of images of both modalities and enabled a more 
straightforward use of PET information on MRI-guided 
surgery [7]. Second, the inclusion of PET quantification 
techniques, such as Atlas-based Asymmetry Indices (AI) and 
Statistical Parametric Mapping (SPM) on the clinic has 
improved the localization of the epileptogenic focus [8] [9]. 
Despite of these advancements, the sensitivity of PET is still 
relatively low in epilepsy [6] [5] [10] [9], especially when 
dealing with small focal hypometabolisms, due to the limited 
resolution of PET images. This is extremely important since 
the size of the hypometabolism is inversely correlated with the 
surgery outcome [11]. In this context, techniques that can 
provide an improvement on PET resolution have a great 
potential to improve the localization of these small 
hypometabolisms and consequently the surgery outcome.  
In this context, several approaches have been suggested for 
the use of supplementary MRI-based structural information for 
the resolution recovery (RR) of PET images [12] [13]. These 
techniques have some advantages compared to conventional 
RR approaches modeling the point-spread function (PSF) into 
the reconstruction, especially due to better noise handling [14] 
[15]. Furthermore, many reconstruction algorithms exploiting 
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anatomical information during reconstruction to reduce the 
noise while keeping the high resolution have been proposed in 
literature [16] [17]. Recently, the use of an anatomical brain 
atlas was introduced as a source of structural information for 
the improvement of PET resolution [12] [18] [19]. The use of 
high-frequency structural information enhances the resolution 
of the PET images without significantly altering its functional 
patterns. One of the most promising techniques using this 
approach is the Structural Functional Synergistic Resolution 
Recovery (SFS-RR) [18], which has provided excellent results 
on simulations, phantoms and in some particular clinical case 
with both neurology and oncology patients [20] [21] [22] [23]. 
This methodology may have potential impact in clinical 
decision-making in epilepsy since it can produce images with 
enhanced contrast and improved lesion detectability in the 
visual inspection of PET data. Nevertheless, the method has 
some shortcomings. First, in SFS-RR an atlas with white and 
grey matter information obtained from the MRI (usually a T1 
image) is filled with quantitative values obtained from the 
PET image. These values are affected by Partial Volume 
Effect (PVE), which will limit the accuracy of the correction. 
Second, wavelet decomposition is a very time consuming 
process due to the large number of pixels in clinical MR 
images. The use of larger voxels can remarkably reduce this 
time demand but it could have an impact on the segmentation 
accuracy. These limitations should be assessed before the 
widespread use of this methodology in clinical routine 
In this work, we aim at developing, optimizing and 
evaluating a novel methodology for the iterative application of 
SFS-RR (iSFS-RR). We evaluate the potential of the 
developed methodology to provide an improved localization 
of small focal hypometabolisms and consequently an 
improvement in the diagnosis of focal disorders such as 
epilepsy. For this, a group of patients previously diagnosed 
with refractory epilepsy was re-evaluated using images partial 
volume corrected with the novel methodology.  
 
II.! METHODS 
A.! SFS-RR 
 
The wavelet transform (WT) provides a framework to 
decompose images into a number of new images, each one of 
them with a different degree of resolution [24]. The basic idea 
of RR using wavelets is to decompose the functional (PET or 
SPECT) and the structural reference image (MRI, CT or other) 
into several resolution elements using the wavelet transform 
(WT) and then replace the high-resolution components of the 
functional image with the ones of the anatomical image with 
an appropriate local scaling.  This way, details of the high-
resolution image are extracted, transformed and integrated into 
the low-resolution image [25]. The main limitation of wavelet-
based RR is that functional and anatomical distributions may 
differ leading to artifacts or alterations of the functional 
patterns on the final functional images. To prevent this, the 
replacement of functional with structural information is 
performed locally by evaluating the ratio between functional 
and structural signal in the wavelet domain. However, this 
may not be sufficient as no single structural image may 
provide the anatomical support for the functional study at 
hand. An alternative solution is to use an anatomical 
Figure 1: Workflow of SFS-RR and the proposed iSFS-RR.   
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frequency-based brain atlas as a source of structural 
information for the RR process [18].  
 
Figure 1 (red box) shows the steps of the SFS-RR correction 
proposed by Shidahara et al. [18]: 
 
(a) T1-MRI is segmented into white and grey matter and 
this information combined with the Hammersmith atlas to 
generate a probabilistic anatomy-based atlas with Regions of 
Interest (ROIs) for grey and white matter.  
(b) Each Region of Interest (ROI) of the generated 
anatomy-based atlas is filled with the average uptake in the 
patientÕs PET scan for each ROI, generating a segmented atlas 
with anatomical and functional information.  
(c) The PET image and the corresponding segmented atlas 
are decomposed into several resolutions using the dual-tree 
complex wavelet transform (CWT) [26], which decomposes 
the image into multiple directional features (six quadrants with 
directionalities ±15¡, ±45¡ and ±75¡).  
(d) The high frequencies from the segmented atlas are 
weighted using three levels of scaling and introduced into the 
PET data. The high-resolution wavelet coefficients of the 
corrected image are calculated as: 
 
�∀#∃∃ = � ∙ � ∙ � ∙ �∗+,	 + (1 − �) ∙ �345} 
 
where �∗+,, �345 , �∀#∃∃ are the segmented atlas, PET and 
corrected PET wavelet coefficients, � is a coefficient 
accounting for the difference in resolutions between the two 
images, � is the branching factor that weights anatomical 
versus functional information and �	is a global calibration 
factor compensating for the different intensity between 
anatomical and PET wavelet coefficients.  
(e) Finally, the PET image is recomposed resolution-
recovered. 
 
B.! iSFS-RR 
 
The accuracy of SFS-RR when applied to clinical data is 
limited by PVE, which significantly bias the generation of the 
PET-based segmented atlas, an essential step of the correction. 
In this work, we propose an iterative method for the 
application of the SFS-RR (iSFS-RR), which could potentially 
solve the PVE problem. Since the output of the SFS-RR is 
corrected for PVE, it can be used to re-generate the segmented 
atlas and perform the correction again, obtaining a more 
accurate result. The wavelet coefficients of the corrected 
image are for iteration n are calculated as: 
 
�∀#∃∃(8) = �8 ∙ �8 ∙ �8 ∙ �
∗+,(8)	 + (1 − �8) ∙ �
∀#∃∃(89:)} 
 
where �8, �8 and �8 are the updated coefficients. This 
process can be repeated until the output PET and the 
segmented atlas are converging to a stable results. Figure 1 
(orange box) illustrates the proposed iterative loop.  The first 
iteration of this process is equivalent to the conventional SFS-
RR.  
C.! Patients 
In this work we retrospectively re-evaluated images from 18 
patients with intractable temporal lobe epilepsy (TLE). These 
patients have been previously diagnosed and operated by the 
Refractory Epilepsy Surgery Unit at the University Hospital of 
Santiago de Compostela in the period 2012-2013. Following 
the Refractory Epilepsy Surgery Unit protocol, all of them 
underwent FDG-PET, 3T-MRI, video electro-
encephalography and a wide range of neurological and 
neuropsychological tests. The epilepsy diagnosis and focus 
localization was obtained evaluating the results coming from 
the whole group of tests. We also used images from 97 control 
subjects. These images were obtained from pre-treatment 
oncologic patients that underwent FDG-PET after signed 
consent. As the oncology protocol in our center fix a waiting 
time of 1 hour and the brain imaging protocol fix a waiting 
time of 45 minutes, the brain bed was acquired previous to the 
whole-body PET. All of the control subjects were examined 
for ensuring that there are no signs of a neurologic or 
psychiatric disease and the obtained images were evaluated by 
two experienced nuclear medicine physicians and were 
considered normal. All the images were acquired following 
the protocols detailed below.  
D.! Imaging protocols 
a) FDG-PET: all patients underwent the routine 
neuroimaging protocol at our institution. The patient lays at 
rest in a dark and quiet room after intravenous injection of 370 
MBq of 
18
F-FDG. Starting 45 min after injection, the patient 
was scanned during 30 min for emission data and 15 min for 
transmission data, required for attenuation correction. The 
imaging device was a GE Advance NXi PET scanner (General 
Electrics Healthcare, Little Chalfont, Buckinghamshire, 
United Kingdom). Following the default protocols of the GE 
Advance, scatter, randoms, attenuation and normalization 
corrections were applied before the reconstruction. PSF 
modeling and motion correction were included. The images 
were reconstructed using 3D ordered subsets expectation 
maximization (3D-OSEM), with 4 subsets and 16 iterations. 
The size of the reconstructed image is 128x128x35, with a 
voxel size of 2×2×4.25 mm
3
.
 
No smoothing was applied 
during or after the reconstruction.  
b) 3T-MRI: structural imaging was performed with an 
Achieva 3.0T X-series MR imaging scanner (Philips 
Healthcare, Best, The Netherlands) using a head coil. The 
MRI protocol consisted of the acquisition of T1-weighted 3D 
TFE, FLAIR and T2-weighted sequences. The different 
sequences were visually evaluated for diagnosis following the 
protocols of the Refractory Epilepsy Surgery Unit. 
Additionally, the T1-weighted 3D TFE was used as an input 
for the PVE correction.  
 
E.! Image Analysis  
 
PET and T1-MRI sequences were co-registered and 
analyzed using statistical parametric mapping (SPM) software 
package (SPM12, Wellcome Trust Centre for Neuroimaging, 
> REPLACE THIS LINE WITH YOUR PAPER IDENTIFICATION NUMBER < 
 
4 
 
4 
University College London, United Kingdom). PET images 
were evaluated using visual inspection of PET/MR co-
registered images, calculations of asymmetry indices (AI) and 
a voxel-by-voxel statistical comparison. Figure 2 shows an 
example of the results of the performed analysis.  
a) PET/MR co-registering: The co-register of T1-MRI and 
PET images was performed with the SPM package. The used 
algorithm is similar to the one presented by Collignon et al. 
[27]. The original interpolation method described in this paper 
has been changed in order to give a smoother cost function in 
order to make the cost function as smooth as possible, to give 
faster convergence and less chance of local minima. The co-
registered PET has the same matrix and pixel size of the MR 
image.  
b) Asymmetry Indices: The asymmetry calculations were 
based on the ROIs of the Hammersmith atlas [28], specifically 
designed for TLE. The group of 97 control subjects was used 
for generating a template of the average uptake of the healthy 
brain on the Montreal Neurological Institute (MNI). The 
original T1-MRI images were normalized to the MNI space 
using SPM. Spatial normalization is done via a segmentation 
routine [29]. The transformation matrix is inverted and applied 
to the atlas and the healthy brain template, taking them to the 
patient space. The PET image (co-registered to the T1-MRI) is 
proportionally scaled to the healthy brain template to eliminate 
global differences. Afterwards, differences on the average 
uptake between the patient PET (VMp) and the healthy 
template (VMc) are calculated for each ROI on the Atlas and 
contralateral ROIs and are compared to obtain asymmetry 
indices as: 
�� % = [(��Α � − ��∀(�))
��∀ �
−
(��Α � − ��∀(�))
��∀ �
]�100 
where L and R stand for left and right sides of the brain. AIs 
higher than 5% were considered significant based on the 
intrinsic AI variability obtained from the controls.  
c) Voxel-by-voxel analysis: The calculated normalization 
matrix is applied to the PET image to take it to the MNI space. 
Afterwards, the patient is compared to the group of 97 healthy 
patients using a two-sample t-test [30]. All images, including 
the patient PET image, were smoothed using a 4-mm Gaussian 
filter. Proportional scaling was used to remove the global 
differences between subjects. Clusters of 100 pixels with T-
scores higher than 3.5 were considered significant.  
A positive PET report was emitted when the 
hypometabolism was observed in the visual inspection (VI) of 
the PET/MR image and it was reported as positive by the AIs 
of the SPM of the quantitative analyses  (VI!(AI+SPM)). 
Following the aforementioned evaluation protocol, all patients 
were evaluated by using original PET images and PET images 
corrected with SFS-RR and with the proposed iSFS-RR 
method. Figure 1 shows an example of the performed analysis 
where the 3 tests gave a true localization of the focus.  
 
F.! iSFS-RR Convergence Evaluation 
 
The convergence of the was evaluated using subtraction 
images of corrected PET images of consecutive iterations. To 
evaluate this global convergence, we measure two parameters, 
named maximum change (MC) and average change (AC) and 
defined as:  
 
 
��	 % =
max	 ��� �� � − �� � − 1
�������	 �� �
�100 
 
��	(%) =
average	 ��� �� � − �� � − 1
�������	 �� �
�100 
 
were it(n) is the actual iteration and it(n-1) is the previous 
iteration. We also investigate the impact of different input 
MRI image sizes on the correction outcome. The latter is 
especially significant for the high time demand proposed 
methodology since wavelet decomposition is iteratively 
performed. To evaluate this, we generated corrected images 
using inputs of two different sizes: 256×256×175 pixels of 
1×1×1 mm
3
 and 128×128×87 pixels of 2×2×2 mm
3
. The 
whole process including the segmentation and alignment of 
the MR and the Hammersmith atlas for the generation of the 
probabilistic anatomy-based atlas was performed for the two 
subsets. We evaluated the variations along the iterations of the 
Figure 2: Example of the performed image analysis. PET/MR 
co-registered images showing a hypometabolism on the right 
temporal lobe (A), Asymmetrical ROIs from the AI analysis (B) 
and results of the voxel-by-voxel comparison from SPM (C). In 
(C) images are shown in the Montreal Neurological Institute 
space.  
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obtained final quantification values (AIs and SPM T-scores) in 
a sample of 10 patients with previously identified small (5) 
and extended (5) hypometabolisms.  
 
  
AI change (%) SPM change (%) 
Patient H.M. Type 128pix 256pix 128pix 256pix 
1 Extended 0,77 2,58 0,00 2,52 
2 Extended 1,21 -2,07 -2,55 1,65 
3 Extended 6,51 0,61 1,49 2,19 
4 Extended 5,78 -0,50 8,19 9,89 
5 Extended 5,30 -0,08 4,82 9,84 
6 Focal 1,27 -0,09 30,71 17,10 
7 Focal -5,30 -1,54 17,97 12,64 
8 Focal 12,58 7,32 19,51 15,17 
9 Focal 0,95 -0,58 45,55 52,42 
10 Focal 2,43 6,60 16,79 21,46 
 
Table 1: Relative changes of AIs and SPM T-scores for a group of 
10 patients for different hypometabolism sizes between original and 
iSFS-RR corrected PET images.; 
(a)
1.5 minutes per iterations (7.5 
minutes for 5 iterations); 
(b)
5 minutes per iteration (25 minutes for 5 
iterations) on Intel Xeon CPU E3-1241 v3 @ 3.50 GHz. 
 
G.! Clinical Evaluation 
After the convergence evaluation we fixed a number of  
iterations for applying the iterative method. The optimized 
protocol was applied to our database of 18 epilepsy patients. A 
complete patient report was obtained for images corrected 
with SFS-RR and with the proposed iSFS-RR. The clinical 
evaluation was performed with images of 256×256×175 pixels 
of 1×1×1 mm
3 
since they were found more convenient for the 
visual inspection. The results were compared with those of the 
original PET in order to evaluate the improvements due to the 
application of SFS-RR and iSFS-RR. 
III.! RESULTS 
A.! Optimization of the iSFS-RR 
Figure 3 shows the obtained PET images along the 
iterations for a particular patient. At the bottom of the figure 
we show the difference images between consecutive iterations 
for each of the images above. It can be observed in both cases 
that the method produces images that have visually converged 
as intended. Figure 4 shows MC and AC values obtained from 
iteration 1 to 12 for this patient. Convergence was similar for 
the whole group, ranging from 4-6 iterations for ensuring MC 
changes below 5% and AC changes below 2%. No correlation 
was found between the focus size and the needed number of 
iterations. 6 iterations were finally chosen for the subsequent 
analysis of iSFS-RR as a reasonable option after balancing 
accuracy and computing time. 
Table 1 shows the relative increase of AI and SPM T-score 
values after 6 iterations for 128 and 256 input image sizes. 
The averaged AIs increases were of 3.91% (128 pixels) and 
0.11% (256 pixels) for the extended hypometabolisms, and 
2.38% (128 pixels) and 2.81% (256 pixels) for the focal 
hypometabolisms. The averaged T-scores increases were of 
2.39% (128 pixels) and 5.21% (256 pixels) for the extended 
Figure 3: Original PET and corrected images for 1, 3, 5, 8 and 12 iterations (top) and difference images compared with the previous iteration 
for each of the top images (bottom). 
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hypometabolisms and 26.10% (128 pixels) and 23.75% (256 
pixels) for the focal hypometabolisms.  
Figure 5 shows T-score values along the iterations for 
patients with extended and focal hypometabolisms (iteration 1 
is equivalent to the conventional SFS-RR). It can be observed 
that T-score values converge after iteration 6 for both focual 
and extended hypometabolisms. It can be observed that both 
128 and 256 pixel image sizes converged similarly based on 
the analysis of this particular analysis.  
B.! Clinical Evaluation 
 
Figure 6 shows a visual comparison between original, 128 
and 256 pixels corrected images (iSFS-RR, 6 iterations) for a 
particular patient. We can observe the lesion on the temporal 
lobe better contrasted on the PVE corrected images. Despite 
both 128 and 256 pixel corrected images showed similar 
quantitative results on previous section, it can be observed 
that 256 pixel images show higher level of detail. The 
clinical visual inspection was performed on 256 pixel 
images, where we obtained 14/18 (78%) positives with the 
uncorrected images, 15/18 (83%) positives with the SFS-RR 
corrected images, and 17/18 positives (94%) with the 
proposed iterative methodology.  Regarding the quantitative 
evaluation, the AIs analysis gave a positive localization of the 
focus for 16/18 (88%) of the patients regardless of the used 
methodology and the SPM statistical analysis returned 9/18 
(50%) positives for uncorrected images, 12/18 (66%) for SFS-
RR corrected images and 14/18 (78%) for the proposed 
methodology. The final PET report gave a positive 
Figure 5: Variation of the SPM T-score values with the number of 
iterations for 4 of our patients. Patients 4 and 5 are examples of 
extended hypometabolisms, while patients 7 and 9 are examples of 
focal hypometabolisms. 
 Figure 4:  Maximum and average change per voxel for each iteration 
from 1 to 12 iterations. 
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localization for 14/18 patients (78%) for uncorrected images, 
15/18 (83%) for SFS-RR corrected images and 17/18 (94%) 
for iSFS-RR. Table 2 shows the full PET reports obtained with 
uncorrected images, SFS-RR and iSFS-RR. 
 
IV.! DISCUSSION 
 
The application of PET in neurological diseases related with 
small focal hypometabolic areas have been usually hindered 
by the limited resolution. Improving this can be performed 
using two main approaches: image reconstruction with PSF 
modeling, which can include the use of anatomical priors to 
guide the regularization, or by applying post-reconstruction 
PVE correction methods [14].  These last techniques are based 
on image enhancement by post-processing, either by 
deconvolution or by incorporating high frequency information 
taken from a structural image [31]. These techniques have 
particular advantages compared with the PSF modeling 
approach, mainly better noise handling. In Shidahara et al. 
(2009) [18], it was shown that improved performance of these 
wavelet-based methods could be achieved by using a 
segmented atlas image instead of the raw CT or MR data. An 
important limitation of this approach is that the PET is used to 
construct the segmented atlas, and this information, affected 
by PVE, can limit the effectiveness of the RR technique. This 
work aimed at the evaluation of an iterative application of the 
SFS-RR that can potentially solve this issue. The proposed 
methodology has points in common with the iterative Yang 1 
proposed by Erlandsson et al [14], where instead of using the 
WT the authors propose an iterative correction based on the 
region-based voxel-wise correction (RVB).  The methodology 
for updating the source image is similar to the Ôiterative partial 
volume effect correctionÕ (itPVEC) recently proposed by 
Shcherbinin and Celler [32]. An assessment of the proposed 
methodology was firstly carried out in terms of convergence 
and input image sizes. The study of convergence showed that 
iSFS-RR converges after 6 iterations, providing differences 
between consecutive images below 5% (maximum) and 2% 
(average). The performance of the proposed methodology in 
terms of input image sizes showed that AIs and T-score values 
were increased with respect to uncorrected images similarly 
for 128 and 256 input image sizes, after 6 iterations. In 
particular, the latter study showed that T-score values were 
significantly increased for the focal hypometabolisms, both for 
128 and 256 input image sizes, thus showing that the good 
quantitative performance of the proposed iSFS-RR. We 
concluded that the quantitative improvement was similar 
regardless of the input image size, thus showing that time 
performance can be improved by a factor three without 
significant changes in iSFS-RR outcome. 
Figure 6: Visual comparison of original PET, 128 pixels and 256 pixels corrected images. On the image, coronal slices of the temporal lobe of a 
pathological patient. White circle points the lession 
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After validation and optimization of the methodology, the 
technique was applied to a group of 18 patients previously 
diagnosed with refractory epilepsy. Comparisons in terms of 
sensitivity between uncorrected images, SFS-RR and iSFS-RR 
images were carried out. Regarding the visual inspection, 
sensitivity was improved from 78% to 83% and 94% with 
SFS-RR and iSFS-RR respectively. It has to be mentioned that 
the physicians also gave overall a more complete description 
of the lesions for iSFS-RR and SFS-RR, especially when the 
hippocampus was involved. Regarding the quantitative 
evaluation, the sensitivity of SPM scores was increased from 
50% for uncorrected images to 66% for SFS-RR images and 
83% for iSFS-RR images. This is due to that corrected images 
have better contrast and therefore T-scores values are 
increased so that more significant differences between the 
patient and the control group can be reported. The sensitivity 
of AIs evaluation was 88% regardless of used image, thus 
showing that the spatial resolution improvement derived from 
SFS-RR and iSFS-RR corrections does not affect AIs values. 
This can be explained by the size of the involved ROIs, where 
the exchanges of counts will happen mainly between white 
and grey matter within the ROI. Regarding the final report, the 
sensitivity of the combined evaluation was increased from 
78% to 83% for SFS-RR and 94% for iSFS-RR. Although this 
was mainly derived from the better localization on the visual 
inspection, it is valuable to mention that iSFS-RR improved 
the SPM sensitivity, leading to better sensitivities both on 
visual and SPM evaluations. This is a valuable result for 
increasing the contribution of quantification to the process.   
V.! CONCLUSIONS 
A method for the improvement of brain PET spatial 
resolution based on MRI information was developed and 
clinically evaluated in patients with epilepsy. Our findings 
showed that iSFS-RR provided an improved localization of 
small focal hypometabolisms and consequently an increase in 
the sensitivity of the diagnosis from 78% to 94%. 
Furthermore, iSFS-RR improved the sensitivity of the SPM 
analysis, which is essential for its future integration in clinical 
routine.   
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Table 2: Results of the visual inspection, the AIs quantification and the SPM stat analysis for our group of 18 patients and for uncorrected images, 
SFS-RR corrected images and for iSFS-RR corrected images. On this table, 1 represents a true positive while Ò-Ò represents a negative. The SPM 
columns reflect the maximum values within the clusters. 
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